Second Opinion: Laetrile at Sloan-Kettering (2014)

Second Opinion: Laetrile at Sloan-Kettering is a compelling documentary directed by Eric Merola. Released in 2014, this film sheds light on a controversial chapter in cancer research and treatment. Let’s explore the key revelations from this thought-provoking documentary:

  1. Laetrile and Cancer Treatment:
    • Laetrile, also known as amygdalin or vitamin B17, gained attention as a potential alternative cancer treatment.
    • Derived from apricot kernels, it was believed to have anti-cancer properties.
  2. Sloan-Kettering Cancer Center:
    • The documentary focuses on the renowned Sloan-Kettering Cancer Center in New York.
    • During the 1970s, Sloan-Kettering conducted studies on Laetrile, leading to significant controversy.
  3. The Cover-Up Allegations:
    • Dr. Kanematsu Sugiura, a co-inventor of chemotherapy, was the lead scientist in the Laetrile studies at Sloan-Kettering.
    • Allegedly, positive results from Laetrile trials were suppressed, and the substance was discredited.
  4. Human Trials Set Up to Fail:
    • The FDA and the National Cancer Society allegedly didn’t trust Sloan-Kettering to host unbiased clinical trials.
    • Instead, they chose a leading Laetrile opponent to oversee the human trials, potentially ensuring negative outcomes.
  5. Media Manipulation and Rebranding:
    • As Laetrile gained traction, it was rebranded as toxic, even though it was considered non-toxic.
    • The establishment aimed to sway public opinion away from seeking Laetrile.
  6. Ethical Questions and Ralph W. Moss:
    • Ethical dilemmas arose as Laetrile faced scrutiny.
    • Ralph W. Moss, PhD, played a pivotal role in exposing the truth about Laetrile and cancer research.
  7. The Shift in Paradigm:
    • The documentary challenges viewers to question the cancer industry and consider alternative therapies.
    • It highlights the importance of transparency, informed choices, and critical thinking.

In a world where cancer treatments remain a battleground, Second Opinion: Laetrile at Sloan-Kettering invites us to explore suppressed knowledge and seek truth beyond conventional narratives. 

Spread the love

Leave a Reply